Missing person image small Ralf Koberstein

Representative before the EPO

Missing person image thumb Missing person image thumb Missing person image thumb
Technology company logo thumb
no operation time available
Actelion Pharmaceuticals Ltd.
1 office
Technology Company

Representative before the EPO

Missing person image thumb Missing person image thumb
Technology company logo thumb
no operation time available
Idorsia Pharmaceuticals Ltd
1 office
Technology Company

We have observed 33 EP applications Ralf Koberstein has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after February 27, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12756563

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/436, A61K 31/4355, C07D 491/052, C07D 491/048, A61P 29/00
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ NO OPPOSITION FILED WITHIN TIMELIMIT
EP12823031

HETEROCYCLYL DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS

IPC classification:
A61K 31/47, C07D 417/06, C07D 413/06, C07D 405/06, C07D 401/12, C07D 401/06, C07D 223/16, C07D 223/06, C07D 217/06, C07D 209/44
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ PATENT GRANTED
EP13707053

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4355, C07D 491/048, A61P 29/00
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ NO OPPOSITION FILED WITHIN TIMELIMIT
EP13712913

4-(BENZOIMIDAZOL-2-YL)-THIAZOLE COMPOUNDS AND RELATED AZA DERIVATIVES

IPC classification:
A61K 31/427, C07D 519/00, C07D 487/04, C07D 471/04, C07D 417/14
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ PATENT GRANTED
EP13731938

FLUORINATED BRIDGED SPIRO[2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AGONISTS

IPC classification:
A61K 31/44, A61K 31/40, C07D 211/58, C07D 207/34, A61P 31/12, A61P 29/00, A61P 9/00
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ PATENT GRANTED
EP13731930

1-(P-TOLYL)CYCLOPROPYL SUBSTITUTED BRIDGED SPIRO[2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AGONISTS

IPC classification:
A61K 31/40, C07D 207/10, C07D 207/08, A61P 3/00
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ PATENT GRANTED
EP13762258

1-PHENYL-SUBSTITUTED HETEROCYCLYL DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS

IPC classification:
A61K 31/4353, C07D 513/04, A61P 37/00, A61P 17/00, A61P 11/00
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ EXAMINATION IN PROGRESS
EP13824192

INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/506, A61K 31/405, C07D 498/08, C07D 417/12, C07D 413/14, C07D 413/12, C07D 405/14, C07D 403/14, C07D 403/12, C07D 401/14, C07D 401/12, C07D 209/08, A61P 25/28, A61P 19/00, A61P 11/00
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ PATENT GRANTED
EP13826623

INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/404, C07D 209/24, C07D 209/08, A61P 29/00
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ PATENT GRANTED
EP14706331

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS& xA;

IPC classification:
A61P 29/00, A61P 25/00, C07D 277/60, A61K 31/429, A61K 31/428
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ PATENT GRANTED
EP14703442

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

IPC classification:
A61P 29/00, A61K 31/429, A61K 31/428, C07D 277/60, C07D 513/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ PATENT GRANTED
EP14715427

PYRIDIN-4-YL DERIVATIVES

IPC classification:
A61P 37/00, A61K 31/4433, C07D 413/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
█ The patent has been granted
EP14715428

NOVEL ACRYLAMIDE DERIVATIVES AS ANTIMALARIAL AGENTS

IPC classification:
A61K 31/445, A61K 31/435, C07D 211/58, C07D 471/04, C07D 417/14, C07D 401/12, C07D 213/75, C07D 413/14, C07D 401/14, C07D 403/12
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
█ The patent has been granted
EP14732206

DIFLUOROETHYL-OXAZOLE SUBSTITUTED BRIDGED SPIRO[2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AGONISTS

IPC classification:
A61K 31/422, C07D 413/12
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ PATENT GRANTED
EP14739472

PIPERAZINE SUBSTITUTED BRIDGED SPIRO[2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AGONISTS

IPC classification:
A61K 31/495, C07D 295/14
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ The patent has been granted
EP14781943

BENZIMIDAZOLYL-METHYL UREA DERIVATIVES AS ALX RECEPTOR AGONISTS

IPC classification:
A61P 29/00, A61K 31/4184, C07D 473/00, C07D 471/04, C07D 453/02, C07D 417/12, C07D 413/12, C07D 405/12, C07D 401/12, C07D 235/14, C07D 403/12
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ PATENT GRANTED
EP14781948

ANTIBACTERIAL 2H-INDAZOLE DERIVATIVES

IPC classification:
A61K 31/416, C07D 413/10, C07D 403/06, C07D 401/06, C07D 231/56
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
█ The patent has been granted
EP14812752

ANTIBACTERIAL 1H-INDAZOLE AND 1H-INDOLE DERIVATIVES

IPC classification:
A61P 31/04, A61K 31/416, A61K 31/404, C07D 209/08, C07D 409/06, C07D 403/06, C07D 231/56
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
█ The patent has been granted
EP15707154

1,2-DIHYDRO-3H-PYRROLO[1,2-C]IMIDAZOL-3-ONE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS

IPC classification:
A61K 31/496, A61K 31/5377, A61K 31/4188, C07D 487/04
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
█ The patent has been granted
EP15714032

AZAINDOLE ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS

IPC classification:
A61P 37/00, A61K 31/437, C07D 471/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ EXAMINATION REQUESTED
EP15714030

AZAINDOLE ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS

IPC classification:
A61P 37/00, A61K 31/437, C07D 471/04
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ EXAMINATION REQUESTED
EP15714957

8-(PIPERAZIN-1-YL)-1,2,3,4-TETRAHYDRO-ISOQUINOLINE DERIVATIVES

IPC classification:
A61P 25/28, A61P 35/00, A61P 37/00, A61K 31/4725, C07D 471/04, C07D 417/14, C07D 413/14, C07D 401/14
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ The patent has been granted
EP15722212

ANTIBACTERIAL QUINAZOLINE-4(3H)-ONE DERIVATIVES

IPC classification:
A61P 31/04, A61K 31/517, C07D 239/90
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
█ The patent has been granted
EP15728640

PYRAZOLE COMPOUNDS AND THEIR USE AS T-TYPE CALCIUM CHANNEL BLOCKERS

IPC classification:
A61P 35/00, A61P 25/00, A61P 15/00, A61P 9/00, A61P 3/10, A61K 31/4439, A61K 31/4155, A61K 31/415, C07D 471/04, C07D 413/12, C07D 405/12, C07D 401/12, C07D 401/06, C07D 231/40, C07D 405/14, C07D 401/14, C07D 403/12
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ The patent has been granted
EP15763321

TRIAZOLE COMPOUNDS AS T-TYPE CALCIUM CHANNEL BLOCKERS

IPC classification:
A61P 35/00, A61P 9/00, A61K 31/4192, C07D 405/12, C07D 403/12, C07D 401/12, C07D 249/04
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
█ The patent has been granted
EP16700484

HYDROXYALKYL-PIPERAZINE DERIVATIVES AS CXCR3 RECEPTOR MODULATORS

IPC classification:
A61P 37/00, A61K 31/427, C07D 417/14
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Status:
█ The patent has been granted
EP16700487

(R)-2-METHYL-PIPERAZINE DERIVATIVES AS CXCR3 RECEPTOR MODULATORS

IPC classification:
A61P 29/00, A61K 31/427, C07D 417/14
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Status:
█ The patent has been granted
EP16724387

CRYSTALLINE FORM OF THE COMPOUND (S)-3-{4-[5-(2-CYCLOPENTYL-6-METHOXY-PYRIDIN-4-YL)-[1,2,4]OXADIAZOL-3-YL]-2-ETHYL-6-METHYL-PHENOXY}-PROPANE-1,2-DIOL

IPC classification:
C07D 413/04
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Status:
█ Request for examination was made
EP16751287

SUBSTITUTED 1,2-DIHYDRO-3H

IPC classification:
A61P 31/04, A61K 31/5377, A61K 31/4188, C07D 487/04
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Status:
█ Request for examination was made
EP16757255

ANTIBACTERIAL ANNULATED PYRROLIDIN-2-ONE DERIVATIVES

IPC classification:
A61P 31/04, A61K 31/407, A61K 31/4035, C07D 209/46, C07D 495/04
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Status:
█ Request for examination was made
EP16759792

SUBSTITUTED 1,2-DIHYDRO-3H-PYRROLO[1,2-C]IMIDAZOL-3-ONE ANTIBACTERIAL COMPOUNDS

IPC classification:
A61P 31/04, A61K 31/4188, C07D 519/00, C07D 487/04
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Status:
█ Request for examination was made
EP16763225

ANTIBACTERIAL HETEROCYCLIC DERIVATIVES

IPC classification:
C07D 277/62, A61K 31/428, A61K 31/423, C07D 263/54
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Status:
█ Request for examination was made
EP16769914

CRYSTALLINE FORMS

IPC classification:
A61P 37/00, A61K 31/506, C07D 471/04
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Status:
█ Request for examination was made

Please Sign in to use this feature